FDA releases guidance on 3D printing of medical products

The U.S. Food and Drug Administration (FDA) on December 4 released a new set...Read more on AuntMinnie.comRelated Reading: FDA provides update of Cures Act FDA issues guidance on lowering pediatric x-ray dose FDA releases medical innovation tool Help wanted: FDA seeks hires for digital health team FDA panel votes to add retention warning to GBCA labels
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

Abstract Laryngeal trauma from prolonged endotracheal intubation occurs in patients of all ages. Most changes are superficial and heal quickly. Injuries that are found consistently during intubation include nonspecific changes, edema, granulation tissue, ulceration, and othermiscellaneous injuries. In thispapersignificant, severe, and lasting trauma of the larynx has been classified on thebasis of theknown factors in pathogenesis, observations made atendoscopy, and photographic documentation. This classification has required introduction of new descriptive terminology: "tongues of granulation tissue," &q...
Source: The Annals of Otology, Rhinology, and Laryngology - Category: ENT & OMF Authors: Tags: Ann Otol Rhinol Laryngol Source Type: research
PMID: 30012011 [PubMed - in process]
Source: The Annals of Otology, Rhinology, and Laryngology - Category: ENT & OMF Authors: Tags: Ann Otol Rhinol Laryngol Source Type: research
PMID: 30012010 [PubMed - in process]
Source: The Annals of Otology, Rhinology, and Laryngology - Category: ENT & OMF Authors: Tags: Ann Otol Rhinol Laryngol Source Type: research
PMID: 30012009 [PubMed - in process]
Source: The Annals of Otology, Rhinology, and Laryngology - Category: ENT & OMF Authors: Tags: Ann Otol Rhinol Laryngol Source Type: research
The FDA has approved the first protease inhibitor-based single-tablet regimen for the treatment of HIV-1 infection in treatment-naive and certain virologically suppressed adult patients.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: HIV/AIDS News Alert Source Type: news
Publication date: August 2018Source: The Lancet Neurology, Volume 17, Issue 8Author(s): Henk-Jan Westeneng, Ammar Al-Chalabi, Orla Hardiman, Thomas PA Debray, Leonard H van den Berg
Source: The Lancet Neurology - Category: Neurology Source Type: research
Publication date: August 2018Source: The Lancet Neurology, Volume 17, Issue 8Author(s): Susana Carmona, Kathleen Zahs, Elizabeth Wu, Kelly Dakin, Jose Bras, Rita GuerreiroSummaryAlzheimer's disease is a genetically complex disorder; rare variants in the triggering receptor expressed on myeloid cells 2 (TREM2) gene have been shown to as much as triple an individual's risk of developing Alzheimer's disease. TREM2 is a transmembrane receptor expressed in cells of the myeloid lineage, and its association with Alzheimer's disease supports the involvement of immune and inflammatory pathways in the cause of the disease, rather th...
Source: The Lancet Neurology - Category: Neurology Source Type: research
Publication date: August 2018Source: The Lancet Neurology, Volume 17, Issue 8Author(s): Farhat Husain, Jerry Vanatta
Source: The Lancet Neurology - Category: Neurology Source Type: research
Publication date: August 2018Source: The Lancet Neurology, Volume 17, Issue 8Author(s):
Source: The Lancet Neurology - Category: Neurology Source Type: research
Publication date: August 2018Source: The Lancet Neurology, Volume 17, Issue 8Author(s): Lee H Schwamm
Source: The Lancet Neurology - Category: Neurology Source Type: research
More News: Food and Drug Administration (FDA) | Pediatrics | Radiology | Warnings